What Researchers Did
The authors reviewed how oxygen-based therapies, including hyperbaric oxygen, might be combined with treatments like chemotherapy, radiation, and immunotherapy for cancer.
What They Found
This is a scientific review article summarizing existing research and theory, not a clinical trial, so it reports no patient sample size, dosing protocol, or statistics. The authors describe that tumor oxygenation, delivered clinically through ozone or hyperbaric oxygen therapy, has been shown in animal experiments and clinical settings to inhibit tumor growth and boost the anti-tumor effects of chemotherapy and radiation, though no specific figures are given. They also note tumor oxygenation could enhance treatments that block a tumor's blood supply. Combining oxygen therapy with immune-based treatments (such as checkpoint inhibitors or hyperthermia) is described as something that "could be considered" as a promising approach, not as an established or proven one.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
As a review article rather than an original clinical study, it does not include its own patient data, control groups, or statistical testing, so its claims about oxygen therapy's effects rest on other researchers' animal and clinical work rather than new evidence presented here.